The protein kinase C (PKC) family of serine/threonine kinases functions downstream of nearly all membrane-associated signal transduction pathways. Here we identify PKC-α as a fundamental regulator of cardiac contractility and Ca2+ handling in myocytes. Hearts of Prkca-deficient mice are hypercontractile, whereas those of transgenic mice overexpressing Prkca are hypocontractile. Adenoviral gene transfer of dominant-negative or wild-type PKC-α into cardiac myocytes enhances or reduces contractility, respectively. Mechanistically, modulation of PKC-α activity affects dephosphorylation of the sarcoplasmic reticulum Ca2+ ATPase-2 (SERCA-2) pump inhibitory protein phospholamban (PLB), and alters sarcoplasmic reticulum Ca2+ loading and the Ca2+ transient. PKC-α directly phosphorylates protein phosphatase inhibitor-1 (I-1), altering the activity of protein phosphatase-1 (PP-1), which may account for the effects of PKC-α on PLB phosphorylation. Hypercontractility caused by Prkca deletion protects against heart failure induced by pressure overload, and against dilated cardiomyopathy induced by deleting the gene encoding muscle LIM protein (Csrp3). Deletion of Prkca also rescues cardiomyopathy associated with overexpression of PP-1. Thus, PKC-α functions as a nodal integrator of cardiac contractility by sensing intracellular Ca2+ and signal transduction events, which can profoundly affect propensity toward heart failure.
Subscribe to Journal
Get full journal access for 1 year
only $17.42 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Dempsey, E.C. et al. Protein kinase C isozymes and the regulation of diverse cell responses. Am. J. Physiol. Lung Mol. Physiol. 279, L429–L438 (2000).
Pass, J.M. et al. Enhanced PKCβII translocation and PKCβII-RACK1 interactions in PKCε-induced heart failure: a role for RACK1. Am. J. Physiol. Heart Circ. Physiol. 281, H2500–H2510 (2001).
Ping, P. et al. Ischemic preconditioning induces selective translocation of protein kinase C isoforms ε and η in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ. Res. 81, 404–414 (1997).
MacLennan, D.H. & Kranias, E.G. Phospholamban: a crucial regulator of cardiac contractility. Nat. Rev. Mol. Cell Biol. 4, 566–577 (2003).
MacDougall, L.K., Jones, L.R. & Cohen, P. Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban. Eur. J. Biochem. 196, 725–734 (1991).
Steenaart, N.A., Ganim, J.R., Di Salvo, J. & Kranias, E.G. The phospholamban phosphatase associated with cardiac sarcoplasmic reticulum is a type 1 enzyme. Arch. Biochem. Biophys. 293, 17–24 (1992).
Neumann, J. Altered phosphatase activity in heart failure, influence on Ca2+ movement. Basic Res. Cardiol. 97, I91–I95 (2002).
Bayer, A.L. et al. Alterations in protein kinase C isoenzyme expression and autophosphorylation during progression of pressure overload–induced left ventricular hypertrophy. Mol. Cell. Biochem. 242, 145–152 (2003).
Bowling, N. et al. Increased protein kinase C activity and expression of calcium-sensitive isoforms in the failing human heart. Circulation 99, 384–391 (1999).
Wang, J., Liu, X., Sentex, E., Takeda, N. & Dhalla, N.S. Increased expression of protein kinase C isoforms in heart failure due to myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 284, H2277–H2287 (2003).
Carr, A.N. et al. Type 1 phosphatase, a negative regulator of cardiac function. Mol. Cell. Biol. 22, 4124–4135 (2002).
El-Armouche, A. et al. Evidence for protein phosphatase inhibitor-1 playing an amplifier role in β-adrenergic signaling in cardiac myocytes. FASEB J. 17, 437–439 (2003).
Arber, S. et al. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell 88, 393–403 (1997).
Bibb, J.A. et al. Phosphorylation of the protein phosphatase inhibitor-1 by Cdk5. J. Biol. Chem. 276, 14490–14497 (2001).
Hubbard, M.J., Dent, P., Smythe, C. & Cohen, P. Targeting of protein phosphatase 1 to the sarcoplasmic reticulum of rabbit skeletal muscle by a protein that is very similar or identical to the G subunit that directs the enzyme to glycogen. Eur. J. Biochem. 189, 243–249 (1990).
Champion, H.C. et al. Robust adenoviral and adeno-associated viral gene transfer to the in vivo murine heart: application to the study of phospholamban physiology. Circulation 108, 2790–2797 (2003).
Klein, L. et al. Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations. Am. J. Cardiol. 91, 18F–40F (2003).
Minamisawa, S. et al. Chronic phospholamban–sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. Cell 99, 313–322 (1999).
Hoshijima, M. et al. Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat. Med. 8, 864–871 (2002).
Warner-Stevenson, L. Clinical use of inotropic therapy for heart failure: looking backward or forward? Circulation 108, 492–497 (2003).
Bristow, M.R. β-Adrenergic receptor blockade in chronic heart failure. Circulation 101, 558–569 (2000).
Hahn, H.S. et al. Protein kinase Cα negatively regulates systolic and diastolic function in pathological hypertrophy. Circ. Res. 93, 1111–1119 (2003).
Arber, S. et al. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell 7, 393–403 (1997).
Liang, Q. et al. c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signaling. EMBO J. 22, 5079–5089 (2003).
Bueno, O.F. et al. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J. 19, 6341–6350 (2000).
Westfall, M.V. & Borton, A.R. Role of troponin I phosphorylation in protein kinase C–mediated enhanced contractile performance of rat myocytes. J. Biol. Chem. 278, 33694–33700 (2003).
Petrashevskaya, N.N., Bodi, I., Rubio, M., Molkentin, J.D. & Schwartz, A. Cardiac function and electrical remodeling of the calcineurin-overexpressed transgenic mouse. Cardiovasc. Res. 54, 117–132 (2002).
Masaki, H., Sato, Y., Luo, W., Kranias, E.G. & Yatani, A. Phospholamban deficiency alters inactivation kinetics of L-type Ca2+ channels in mouse ventricular myocytes. Am. J. Physiol. 272, H606–H612 (1997).
Chu, G. et al. Compensatory mechanisms associated with the hyperdynamic function of phospholamban-deficient mouse hearts. Circ. Res. 79, 1064–1076 (1996).
De Windt, L.J., Lim, H.W., Haq, S., Force, T. & Molkentin, J.D. Calcineurin promotes protein kinase C and c-Jun NH2-terminal kinase activation in the heart. Cross-talk between cardiac hypertrophic signaling pathways. J. Biol. Chem. 275, 13571–13579 (2000).
Braz, J.C., Bueno, O.F., De Windt, L.J. & Molkentin, J.D. PKCα regulates the hypertrophic growth of cardiomyocytes through extracellular signal-regulated kinase 1/2 (ERK1/2). J. Cell. Biol. 156, 905–919 (2002).
This work was supported by the National Institutes of Health, an Established Investigator Award from the American Heart Association, and a Pew Charitable Trust Scholar Award (J.D.M.). J.C.B. was supported by a National Institutes of Health training grant (5T32 HL07382). J.A.B. was supported by the National Institute of Drug Abuse. We thank T. Eschenhagen for the I-1-expressing adenovirus and S. Schenolikar for antibodies to I-1 and Thr35-phoshorylated I-1.
The authors declare no competing financial interests.
About this article
Cite this article
Braz, J., Gregory, K., Pathak, A. et al. PKC-α regulates cardiac contractility and propensity toward heart failure. Nat Med 10, 248–254 (2004). https://doi.org/10.1038/nm1000
Protein Kinase C Alpha Cellular Distribution, Activity, and Proximity with Lamin A/C in Striated Muscle Laminopathies
The Implications for Cells of the Lipid Switches Driven by Protein–Membrane Interactions and the Development of Membrane Lipid Therapy
International Journal of Molecular Sciences (2020)
The FEBS Journal (2020)
Current Tissue Microenvironment Reports (2020)
Heart Plasticity in Response to Pressure- and Volume-Overload: A Review of Findings in Compensated and Decompensated Phenotypes
Frontiers in Physiology (2020)